Ifp Advisors, Inc Fate Therapeutics Inc Call Options Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 15, 2019	SELL	$13.15 - $18.71 $10,520 - $14,968	-800 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$11.48 - $16.98 $36,736 - $54,336	-3,200 Reduced 80.0%	800 $10,000
Q3 2018 Oct 25, 2018	SELL	$8.75 - $16.29 $105,000 - $195,480	-12,000 Reduced 75.0%	4,000 $0
Q2 2018 Aug 07, 2018	BUY	$9.16 - $13.48 $135,568 - $199,504	14,800 Added 1233.33%	16,000 $0
Q1 2018 May 09, 2018	BUY	$6.3 - $13.77 $7,560 - $16,524	1,200 New	1,200 $0

176

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $123M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.